← Back to Search

Flavonoids

Elderberry for Coronavirus

N/A
Recruiting
Research Sponsored by Franklin Health Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 13 weeks
Awards & highlights

Study Summary

This trial will test how well ElderCraft® elderberry extract affects immunity.

Eligible Conditions
  • Coronavirus
  • Influenza
  • Common Cold
  • Flu
  • Cold

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~13 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 13 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Duration of Upper Respiratory Events
Incidence of Upper Respiratory Events
Incidence of Upper Respiratory Symptomatic Days
+1 more
Secondary outcome measures
Cognitive Wellbeing
Duration of COVID-19
Duration of influenza
+7 more
Other outcome measures
Adverse Events
Digestive Health

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Intervention ArmExperimental Treatment1 Intervention
Participants will receive a 13-week supply of ElderCraft® (European black elderberry extract standardized to 15% anthocyanins). Each capsule contains 300mg of extract; participants will take a total of two capsules each day.
Group II: Placebo ArmPlacebo Group1 Intervention
Participants will receive a 13-week supply of inert placebo capsules matched for polysaccharide content. Participants will take a total of two capsules each day.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Elderberry
2011
N/A
~80

Find a Location

Who is running the clinical trial?

Artemis InternationalUNKNOWN
1 Previous Clinical Trials
57 Total Patients Enrolled
Franklin Health ResearchLead Sponsor
16 Previous Clinical Trials
3,089 Total Patients Enrolled
IPRONAUNKNOWN
~153 spots leftby May 2025